AI protein design

Design a protein for the job you want it to do

Hybridoma and phage display help us find antibodies. AI lets us design proteins for a chosen binding site and function, then test them in the lab.

A fused cell releases full antibodies.Hybridoma
Thin phages carry antibody fragments at their tips.Phage display
A neural network mesh leads into a folded binder that fits a patch on its target.AI design
Illustrations are not to scale.

Three ways to find a binder

Swipe to compare all three methods.

What to compareHybridomaPhage displayAI design
First hits~2–3 months~2–4 weeks~2–6 weeks
Relative costHighestModerateLow to moderate
Lab screenHundreds to thousands of clonesTens to hundreds of clonesTens to hundreds of designs
Binding siteLimited direct controlCan steer selectionChoose the site up front

Planning estimates for early discovery. Phage display assumes a ready library. AI cost depends on the number of rounds.

Humanising a mouse antibody adds time and cost. Phage display starts with a large, often proprietary library. After selection, teams express fragments in bacteria. They can then reformat hits as full antibodies.

Why use AI?

We engineer proteins around the job they need to do and use lab results to steer each round.

  • Choose the format

    We can design a peptide, a miniprotein or a larger protein. We design for stability and check how well bacteria produce the protein.

  • Engineer the mechanism

    We choose the binding site and how the binder fits. We can design it to bring two proteins together at a chosen angle. Conventional screens rarely select for that geometry directly.

  • Run the next round sooner

    We can start from a model before purified target protein is ready. We generate tens of thousands of designs on a computer and test tens to hundreds. Lab results guide the next round.

See how Fusiomica tests designs
Sources